Hemoshear Therapeutics LLC, of Charlottesville, Va., said it extended its 2017 partnership with Takeda Pharmaceutical Co. Ltd., of Osaka, Japan, for the discovery and development of therapeutics to treat liver diseases, including nonalcoholic steatohepatitis, which so far has generated several drug discovery therapeutic targets. Additional financial terms were not disclosed.